Omixon will attend Molecular Medicine TriConference San Francisco, 11-15 Feb 2013

The Molecular Med Tri-Con is a four day conference which will see more than 3,000 attendees participating in interactive lectures, discussions, and various receptions as a way to facilitate networking opportunities and hearing differing views and perspectives . It includes 2 partnering forums, symposia, short courses, and core programs that covers diagnostics, drug discovery and development, bioinformatics, and cancer biology.

Our CEO, Attila Berces is attending.  Contact us if you would like to schedule a meeting with Attila during this event:  hajnalka.hejja@omixon.com

Omixon will attend Molecular Medicine TriConference San Francisco, 11-15 Feb 2013